Trial Profile
Double-blinded, Randomized, Active Control Comparative, Multicenter-designed, Phase III Clinical Trial to Evaluate the Safety and Efficacy for Improvement of Glabellar Lines of "Botulax" Compared to Botox Inj. in Patients With Moderate to Severe Glabellar Lines
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- Sponsors Hugel
- 06 Jun 2015 New trial record